Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yun‐Song Yang
Observed names:
Y. Yang,
Yun-Song Yang,
Yun-song Yang,
Yunsong Yang
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Huazhong University of Science and Technology
ORCID:
0000-0001-8067-9567
Observed ORCID:
0000-0001-8067-9567
OpenAlex ID:
A5101518938
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
2019
·
Yi-Zhou Jiang
, Ding Ma
, et al.
·
Cancer Cell
·
1,204
PDF
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
2020
·
Yue Gong
, Peng Ji
, et al.
·
Cell Metabolism
·
527
PDF
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
2022
·
Yi Xiao
, Ding Ma
, et al.
·
Cell Research
·
368
PDF
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing
2020
·
Guan-Tian Lang
, Yi-Zhou Jiang
, et al.
·
Nature Communications
·
93
PDF
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
2024
·
Lei Fan
, Zhong-Hua Wang
, et al.
·
The Lancet Oncology
·
88
SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
2020
·
Xi-Yu Liu
, Wang Jiang
, et al.
·
Theranostics
·
60
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
2021
·
Jin-Li Wei
, Si-Yu Wu
, et al.
·
Journal for ImmunoTherapy of Cancer
·
57
PDF
DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas
2015
·
Tu Hu
, Nengbin He
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
48
PDF
Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression
2022
·
Yun-Song Yang
, Xi Jin
, et al.
·
Proceedings of the National Academy of Sciences
·
37
Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer
2023
·
Wen-Ting Peng
, Xi Jin
, et al.
·
Cancer Research
·
34
Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor
2021
·
Li-Ping Ge
, Xi Jin
, et al.
·
Oncogene
·
33
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
2025
·
Tong Fu
, Xi Jin
, et al.
·
Science Translational Medicine
·
31
GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line
2013
·
Dong-dong Cheng
, Hai-guang Zhao
, et al.
·
Biochemical and Biophysical Research Communications
·
30
HSP90 N‐terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2‐driven breast cancer progression
2022
·
Fan Yang
, Rui Sun
, et al.
·
Clinical and Translational Medicine
·
15
The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target
2022
·
Yun-Song Yang
, Yi-Xing Ren
, et al.
·
Breast Cancer Research and Treatment
·
13
PDF
Intravenous leiomyomatosis of the subclavian vein
2016
·
Huimin Fang
, Yun You
, et al.
·
Journal of Vascular Surgery Venous and Lymphatic Disorders
·
10
PDF
Prognostic value of primary tumor surgery in de novo stage IV breast cancer patients with different metastatic burdens: a propensity score-matched and population-based study
2019
·
Yun-Song Yang
, Ying-Le Chen
, et al.
·
Translational Cancer Research
·
8
The safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab in patients with locally recurrent or metastatic triple-negative breast cancer.
2022
·
Lei Fan
, Xiyu Liu
, et al.
·
Journal of Clinical Oncology
·
5
TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer
2026
·
Wen-Ya Wu
, Yun-Song Yang
, et al.
·
Oncogene
·
3
PDF
Landscape of gene fusions in hormone receptor-positive breast cancer reveals ADK fusions as drivers of progression and potential therapeutic targets
2025
·
Yang Ou-Yang
, Ding Ma
, et al.
·
Cell Discovery
·
3
PDF
High Siglec-15 Expression in Triple-negative Breast Cancer Predicts Poor Prognosis
2022
·
Lei Fan
, Xin-Yi Sui
, et al.
·
Research Square
·
1
High Siglec15 Expression in Triple Negative Breast Cancer Predicts Poor Prognosis
2021
·
Peng Zhou
, Yun-Song Yang
, et al.
·
Research Square
·
1
PDF
Supplementary Data from Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer
2025
·
Wen-Ting Peng
, Xi Jin
, et al.
PDF
Multi-modal deep learning model for predicting homologous recombination deficiency in prostate cancer: An international multi-cohort study
2024
·
R. Chen
, Q. Zhang
, et al.
·
European Urology
Differential benefit of capecitabine-based chemotherapy among TNBC subtypes in the context of the CBCSG010 study.
2023
·
Junjie Li
, Wenya Wu
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
34
Citation count:
2,669
H-index:
14
I10-index:
16
Year
Topic
Type